ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs. placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation - Lowery, M A; Abou-Alfa, G K; Valle, J W (J Clin Oncol, 2017)
[Epub ahead of print]